Article ID Journal Published Year Pages File Type
5698256 Clinical Oncology 2016 6 Pages PDF
Abstract
SABR for RCC is safe, the toxicities are minimal, and the local control is excellent at early follow-up. This technique should be further evaluated in prospective clinical trials.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Oncology
Preview
Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma in Non-surgical Candidates: Initial Clinical Experience
Authors
, , , , , ,